134IN - Options and strategies: Project in action: Oral tumour therapy-adherence and safety

Date 28 September 2014
Event ESMO 2014
Session ESMO-EONS: Oral tumour therapy: Collaboration and coordination of healthcare professional activities to enhance patient adherence
Topics Supportive Measures
Presenter Anita Margulies
Citation Annals of Oncology (2014) 25 (suppl_4): iv46-iv47. 10.1093/annonc/mdu320
Authors A. Margulies
  • -, EONS, 8038 - Zurich/CH




Over the last 20 years, development and use of oral cancer drugs increased to approximately 25% of the available cancer drugs on the market, and has transformed the treatment and care setting profoundly. The increase brought changes the therapy regimens from supervised i.v. applications, to continuous oral administration at the patient's home or care setting. Patient information and monitoring pathways have changed accordingly. Oral drug delivery is often well accepted by patients, fewer visits to the clinic may be a result, is less invasive, increases the independence of both patients and caregivers. We also know that the drawbacks of oral cancer drugs are influenced by factors related to the patient, the healthcare professionals and the medicament itself. Physicians, nurses and pharmacists are challenged by previously unknown problem areas. All involved are challenged with increased and new responsibilities. Actively addressing these problems can alleviate many unwanted effects. The project “Adherence with Oral Tumor Therapies” was realized because: - Patients and their caregivers request more and understandable information, cannot rely alone on web-based sources, have false information from undefined sources. - Healthcare professionals need knowledge regarding side effects, barriers to adherence to oral therapies, and assessment techniques to monitor adherence. - Physicians often have less time to communicate with their patients, nurses are an important link and play an important role in patient education and support. A multiprofessional group of medical oncologists and oncology nurses as well as a pharmacist developed a national project to approach these issues. The working group of five persons and the three task groups developed various sub-projects which supported and defined the goals. The pilot project, built on a modular strategy is based on a multiprofessional approach. Organisational aspects and Educational aspects include the following: - a project Website - general information about oral cancer drugs for professionals - patient drug information sheets (per drug) for downloading in clinical settings - free on-site education program for multidisciplinary teams - project evaluation With relatively simple tools, patients and caregivers feel empowered and adhere better.


The author has declared no conflicts of interest.